Drug Companies Pledge 240M COVID-19 Vaccine Doses
Tuesday, February 23, drug companies said that the United States can expect to see a total of 240 million doses of the COVID-19…
J&J Seeks Emergency Authorization for Single-Shot Vaccines
Pharmaceutical giant Johnson & Johnson submitted its single-shot coronavirus vaccine for emergency use authorization after the vaccine was shown to be robustly effective…
J&J to Provide 500M Doses of Vaccine for Poor Countries
Tuesday, December 8, US pharmaceutical giant Johnson & Johnson plans to provide 500 million doses of its coronavirus vaccine for poor countries once…
Johnson & Johnson Starts Two-Dose Trial COVID-19 Vaccine on U.K
Monday, November 16, Johnson & Johnson launched a new late-stage trial in Britain to test two-dose regimen of its COVID-19 candidate vaccine. The…
J&J Pauses Vaccine Trials Due to Unexplained Illness in Participants
Monday, October 12, Johnson & Johnson had temporarily paused its COVID-19 vaccine clinical trial due to an unexplained illness in a study participant.…
Johnson & Johnson’s Single-Dose Vaccine Enters Late-Stage Trials
Pharmaceutical titan Johnson & Johnson has begun its phase three trial testing its potential coronavirus vaccine in 60,000 people enrolled in the trial.…
J&J Plans 60k Subjects to Start COVID-19 Vaccine Trial in September
Johnson & Johnson plan to begin the largest, late-stage trial testing a potential coronavirus vaccine in September. The phase three trial would enroll…
Johnson & Johnson Strikes $6.5 Billion Deal for Momenta
Johnson & Johnson will buy Momenta Pharmaceuticals for about $6.5 billion to bolster its portfolio of treatments for autoimmune diseases. The deal gives…
J&J Starts Human Study of COVID-19 Vaccine after Promising Data
J&J kicked off human safety trials for its COVID-19 vaccine after a study in monkeys showed its best-performing vaccine candidate offered strong protection…
ASEAN HR TECH VENTURE SUMMIT 2018
REGISTER NOW 33% DISCOUNTSUMMIT PASS
Get your tickets now for the
ASEAN HR TECH VENTURE SUMMIT 2018
Sign Up now for the Malacañan Tour
MALACAÑAN TOUR IS AVAILABLE BUT FOR LIMITED SEATS ONLY FOR Sponsorship, Exhibitor and Full Paying Attendees.
If you are one of the above, click the button below to contact us and process your application. Please prepare your conference ID from your registration.
If you have questions about the status of your application or how to obtain access to our events, you can email [email protected]
Send this to a friend